Literature DB >> 18264705

PET imaging with hypoxia tracers: a must in radiation therapy.

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18264705     DOI： 10.1007/s00259-008-0740-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  15 in total

Review 1.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

2.  Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.

Authors:  Amy L Vāvere; Jason S Lewis
Journal:  Dalton Trans       Date:  2007-09-25       Impact factor: 4.390

Review 3.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

4.  Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.

Authors:  Morand Piert; Hans-Jürgen Machulla; Maria Picchio; Gerald Reischl; Sybille Ziegler; Piyush Kumar; Hans-Jürgen Wester; Roswitha Beck; Alexander J B McEwan; Leonard I Wiebe; Markus Schwaiger
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

5.  Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

Authors:  Gerald Reischl; Donna S Dorow; Carleen Cullinane; Andrew Katsifis; Peter Roselt; David Binns; Rodney J Hicks
Journal:  J Pharm Pharm Sci       Date:  2007       Impact factor: 2.327

Review 6.  PET and PET/CT studies of tumor tissue oxygenation.

Authors:  B J Krause; R Beck; M Souvatzoglou; M Piert
Journal:  Q J Nucl Med Mol Imaging       Date:  2006-03       Impact factor: 2.346

7.  Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study.

Authors:  M Souvatzoglou; A L Grosu; B Röper; B J Krause; R Beck; G Reischl; M Picchio; H-J Machulla; H-J Wester; M Piert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-20       Impact factor: 9.236

8.  Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.

Authors:  Anca-Ligia Grosu; Michael Souvatzoglou; Barbara Röper; Martin Dobritz; Nicole Wiedenmann; Vesna Jacob; Hans-Jürgen Wester; Gerald Reischl; Hans-Juergen Machulla; Markus Schwaiger; Michael Molls; Morand Piert
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-01       Impact factor: 7.038

9.  Hypoxia-imaging with (18)F-Misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer.

Authors:  Susanne Martina Eschmann; Frank Paulsen; Claudia Bedeshem; Hans-Jürgen Machulla; Thomas Hehr; Michael Bamberg; Roland Bares
Journal:  Radiother Oncol       Date:  2007-05-31       Impact factor: 6.280

Review 10.  Imaging oxygenation of human tumours.

Authors:  Anwar R Padhani; Kenneth A Krohn; Jason S Lewis; Markus Alber
Journal:  Eur Radiol       Date:  2006-10-17       Impact factor: 5.315
View more
  9 in total

1.  [(68) Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia.

Authors:  Yunkou Wu; Guiyang Hao; Saleh Ramezani; Debabrata Saha; Dawen Zhao; Xiankai Sun; A Dean Sherry
Journal:  Contrast Media Mol Imaging       Date:  2015-06-29       Impact factor: 3.161

Review 2.  Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.

Authors:  Sandip Basu; Babak Saboury; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

3.  Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging.

Authors:  Zhihao Zha; Lin Zhu; Yajing Liu; Fenghua Du; Hongmei Gan; Jinping Qiao; Hank F Kung
Journal:  Nucl Med Biol       Date:  2011-02-04       Impact factor: 2.408

4.  Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.

Authors:  Ludwig J Dubois; Natasja G Lieuwes; Marco H M Janssen; Wenny J M Peeters; Albert D Windhorst; Joseph C Walsh; Hartmuth C Kolb; Michel C Ollers; Johan Bussink; Guus A M S van Dongen; Albert van der Kogel; Philippe Lambin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-23       Impact factor: 11.205

5.  Biodistribution and radiation dosimetry of the hypoxia marker 18F-HX4 in monkeys and humans determined by using whole-body PET/CT.

Authors:  Mohan Doss; James J Zhang; Marie-José Bélanger; James B Stubbs; Eric D Hostetler; Katherine Alpaugh; Hartmuth C Kolb; Jian Q Yu
Journal:  Nucl Med Commun       Date:  2010-12       Impact factor: 1.690

Review 6.  Molecular imaging in cancer treatment.

Authors:  Mark H Michalski; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

7.  Positron Emission Tomography Imaging of Hypoxia.

Authors:  Suzanne E Lapi; Thomas F Voller; Michael J Welch
Journal:  PET Clin       Date:  2009-01-01

8.  Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).

Authors:  Florian C Maier; Manfred Kneilling; Gerald Reischl; Funda Cay; Daniel Bukala; Andreas Schmid; Martin S Judenhofer; Martin Röcken; Hans-Jürgen Machulla; Bernd J Pichler
Journal:  Radiat Oncol       Date:  2011-11-25       Impact factor: 3.481

Review 9.  A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.

Authors:  Nasim Vahidfar; Saeed Farzanefar; Hojjat Ahmadzadehfar; Eóin N Molloy; Elisabeth Eppard
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.